NCT00904111 - A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain | Biotech Hunter

Enrollment

215

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

October 31, 2005

Conditions

Chronic Low Back Pain

Interventions

DRUG

Lidoderm®

Eligible patients were randomly allocated to receive one of two treatments for 12 weeks: lidocaine 5% patch or matching placebo patch.

DRUG

Placebo Topical Patch

Eligible patients were randomly allocated to receive one of two treatments for 12 weeks: lidocaine 5% patch or matching placebo patch.

Trial Locations (18)

Birmingham

Phoenix

Carlsbad

National City

Waterbury

Washington D.C.

Port Orange

Atlanta

Chicago

Overland Park

Pittsfield

Burlington

Altoona

Duncansville

Philadelphia

Cordova

San Antonio

Virginia Beach